Preoperative renin-angiotensin system inhibitors use linked to reduced acute kidney injury: A systematic review and meta-analysis

Nephrology Dialysis Transplantation

Volumn 30, Issue 6, 2015, Pages 978-988

  Cheungpasitporn, Wisit ^a   Thongprayoon, Charat ^a   Srivali, Narat ^a   O'Corragain, Oisin A ^b   Edmonds, Peter J ^c   Ungprasert, Patompong ^a   Kittanamongkolchai, Wonngarm ^a   Erickson, Stephen B ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

acute kidney injury; angiotensin II receptor blockers; angiotensin converting enzyme inhibitors; meta analysis; renin angiotensin system inhibitors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ACUTE KIDNEY FAILURE; ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ACUTE KIDNEY INJURY; DRUG EFFECTS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ACUTE KIDNEY INJURY; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HUMANS; RENIN-ANGIOTENSIN SYSTEM;

EID: 84939608475     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv023     Document Type: Article

References (39)

1. Thongprayoon C, Cheungpasitporn W, Akhoundi A et al. Actual versus ideal body weight for acute kidney injury diagnosis and classification in critically ill patients. BMC Nephrol 2014; 15: 176
2. Hobson C, Ozrazgat-Baslanti T, Kuxhausen A et al. Cost and mortality associated with postoperative acute kidney injury. Ann Surg 2014 [Epub ahead of print]
3. Cheng X, Tong J, Hu Q et al. Meta-analysis of the effects of preoperative renin-angiotensin system inhibitor therapy on major adverse cardiac events in patients undergoing cardiac surgery. Eur J Cardiothorac Surg 2014 [Epub ahead of print]
4. Yacoub R, Patel N, Lohr JW et al. Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies. Am J Kidney Dis 2013; 62: 1077-1086
5. Garg AX, Kurz A, Sessler DI et al. Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. JAMA 2014; 312: 2254-2264
6. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12
7. Stang A. Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
9. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560
10. Easterbrook PJ, Berlin JA, Gopalan R et al. Publication bias in clinical research. Lancet 1991; 337: 867-872
11. Pretorius M, Murray KT, Yu C et al. Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery. Crit Care Med 2012; 40: 2805-2812
12. Argalious M, Xu M, Sun Z et al. Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery. Anesth Analg 2010; 111: 324-330
13. Arora P, Rajagopalam S, Ranjan R et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008; 3: 1266-1273
14. Bandeali SJ, Kayani WT, Lee VV et al. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol 2012; 110: 919-923
15. Barodka V, Silvestry S, Zhao N et al. Preoperative renin-angiotensin system inhibitors protect renal function in aging patients undergoing cardiac surgery. J Surg Res 2011; 167: e63-e69
16. Benedetto U, Angeloni E, Luciani R et al. Acute kidney injury after coronary artery bypass grafting: does rhabdomyolysis play a role? J Thorac Cardiovasc Surg 2010; 140: 464-470
17. Benedetto U, Sciarretta S, Roscitano A et al. Preoperative angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Ann Thorac Surg 2008; 86: 1160-1165
18. Cittanova ML, Zubicki A, Savu C et al. The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Anesth Analg 2001; 93: 1111-1115
19. Coca SG, Garg AX, Swaminathan M et al. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transplant 2013; 28: 2787-2799
20. Dag O, Kaygin MA, Aydin A et al. Is administration of preoperative angiotensin-converting enzyme inhibitors important for renal protection after cardiac surgery? Ren Fail 2013; 35: 754-760
21. Drenger B, Fontes ML, Miao Y et al. Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality. Circulation 2012; 126: 261-269
22. Karkouti K, Wijeysundera DN, Yau TM et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009; 119: 495-502
23. Kheterpal S, Khodaparast O, Shanks A et al. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth 2008; 22: 180-186
24. Kincaid EH, Ashburn DA, Hoyle JR et al. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg 2005; 80: 1388-1393; discussion 1393
25. Metz LI, LeBeau ME, Zlabek JA et al. Acute renal failure in patients undergoing cardiothoracic surgery in a community hospital. WMJ 2009; 108: 109-114
26. Miceli A, Capoun R, Fino C et al. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2009; 54: 1778-1784
27. Ouzounian M, Buth KJ, Valeeva L et al. Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery. Ann Thorac Surg 2012; 93: 559-564
28. Provenchere S, Plantefeve G, Hufnagel G et al. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: incidence, risk factors, and effect on clinical outcome. Anesth Analg 2003; 96: 1258-1264, table of contents
29. Radaelli G, Bodanese LC, Guaragna JC et al. The use of inhibitors of angiotensin-converting enzyme and its relation to events in the post-operative period of CABG. Rev Bras Cir Cardiovasc 2011; 26: 373-379
30. Rader F, Van Wagoner DR, Gillinov AM et al. Preoperative angiotensin-blocking drug therapy is not associated with atrial fibrillation after cardiac surgery. Am Heart J 2010; 160: 329-336 e1
31. Rady MY, Ryan T. The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery. Chest 1998; 114: 487-494
32. Shi P, Li Z, Young N et al. The effects of preoperative renin-angiotensin system inhibitors on outcomes in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27: 703-709
33. Turan A, You J, Shiba A et al. Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery. Anesth Analg 2012; 114: 552-560
34. Yoo YC, Youn YN, Shim JK et al. Effects of renin-angiotensin system inhibitors on the occurrence of acute kidney injury following off-pump coronary artery bypass grafting. Circ J 2010; 74: 1852-1858
35. Brugts JJ, Boersma E, Chonchol M et al. The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial. J Am Coll Cardiol 2007; 50: 2148-2155
36. Kunz R, Friedrich C, Wolbers M et al. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med 2008; 148: 30-48
37. Wagner F, Yeter R, Bisson S et al. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction. Crit Care Med 2003; 31: 1421-1428
38. Ryckwaert F, Colson P, Ribstein J et al. Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 2001; 86: 169-175
39. Abelha FJ, Botelho M, Fernandes V et al. Determinants of postoperative acute kidney injury. Crit Care 2009; 13: R79